Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study

PURPOSE: To investigate the clinical impact of three available antivirals for early COVID-19 treatment in a large real-life cohort. METHODS: Between January and October 2022 all outpatients tested positive for SARS-CoV-2 referring to IRCCS S. Orsola hospital treated with an early antiviral therapy w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinaldi, Matteo, Campoli, Caterina, Gallo, Mena, Marzolla, Domenico, Zuppiroli, Alberto, Riccardi, Riccardo, Casarini, Martina, Riccucci, Daniele, Malosso, Marta, Bonazzetti, Cecilia, Pascale, Renato, Tazza, Beatrice, Pasquini, Zeno, Marconi, Lorenzo, Curti, Stefania, Giannella, Maddalena, Viale, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546723/
https://www.ncbi.nlm.nih.gov/pubmed/37784051
http://dx.doi.org/10.1186/s12879-023-08538-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546723/
https://www.ncbi.nlm.nih.gov/pubmed/37784051
http://dx.doi.org/10.1186/s12879-023-08538-9

Ejemplares similares